Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate
- PMID: 27523470
- DOI: 10.1016/j.reuma.2016.07.005
Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate
Abstract
Patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic drugs are susceptible to severe infections such as leishmaniasis. As L. infantum is endemic in the Mediterranean region, it is necessary to rule this infectious process out in any RA patient presenting with fever and pancytopenia. An early diagnosis based on a high suspicion can prevent a fatal outcome.
Keywords: Artritis reumatoide; Kala-azar; Methotrexate; Metotrexato; Rheumatoid arthritis.
Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
